Infliximab for the treatment of resistant oral ulcers in Behçet's disease: A case report and review of the literature

Galit Almoznino, Eldad Ben-Chetrit*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

Recurrent oral and genital ulceration of Behçet's disease can be very distressing. Usually they are responsive to treatment with topical steroids, local anesthetics, oral colchicine and in severe cases steroids and even immuno-suppressive medications such as azathioprine, methotrexate and thalidomide. We describe a case of Behçet's syndrome in a 48-year old woman whose oral ulcers were resistant to a wide range of topical and systemic treatments and remained unchanged for 7 weeks. Administration of a single dose of infliximab resulted in complete remission and recovery of the mouth aphtae within 7 days. We also review the current English medical literature and summarize 5 more cases where anti-TNF agents were used in the treatment of recalcitrant orogenital ulceration in Behçet's disease.

Original languageEnglish
Pages (from-to)S-99-S-102
JournalClinical and Experimental Rheumatology
Volume25
Issue number4 SUPPL. 45
StatePublished - Jul 2007
Externally publishedYes

Keywords

  • Behçet's disease
  • Infliximab
  • Oral ulcers

Fingerprint

Dive into the research topics of 'Infliximab for the treatment of resistant oral ulcers in Behçet's disease: A case report and review of the literature'. Together they form a unique fingerprint.

Cite this